Thomas Hejkal, MD
Ophthalmology · Omaha, NENPI 1427007780
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $940 and has fallen 51.3% since, to $458 in 2025. Among ophthalmology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $25.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$494
- Sun Pharmaceutical Industries Inc.$467
- Genentech USA, Inc.$420
- Bausch & Lomb Americas Inc.$243
- Bausch & Lomb, A Division Of Bausch Health US, LLC$242
- Biotissue Holdings Inc.$233
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,059100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $494 |
| Sun Pharmaceutical Industries Inc. | 23 | $467 |
| Genentech USA, Inc. | 12 | $420 |
| Bausch & Lomb Americas Inc. | 12 | $243 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $242 |
| Biotissue Holdings Inc. | 1 | $233 |
| Rayner Intraocular Lenses Limited | 9 | $205 |
| Novartis | 6 | $192 |
| Astellas Pharma US Inc | 5 | $187 |
| Oyster Point Pharma, Inc. | 9 | $157 |
| Apellis Pharmaceuticals, Inc. | 9 | $153 |
| Alcon | 7 | $141 |
| Glaukos Corporation | 1 | $132 |
| ANI Pharmaceuticals, Inc. | 1 | $121 |
| Optos, Inc. | 1 | $107 |
| Aerie Pharmaceuticals, Inc. | 6 | $85 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Mallinckrodt Hospital Products Inc. | 2 | $62 |
| Genentech, Inc. | 1 | $61 |
| Tarsus Pharmaceuticals, Inc. | 2 | $57 |
| Alimera Sciences, Inc. | 2 | $45 |
| Mallinckrodt Enterprises LLC | 2 | $39 |
| Harrow Eye, LLC | 1 | $29 |
| Sight Sciences, Inc. | 2 | $28 |
| The Cameron-ehlen Group, Inc. | 2 | $25 |
| Kala Pharmaceuticals, Inc. | 1 | $19 |
| Dompe US, Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $16 |
| Rxsight Inc | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$268
- Prokera$233
- AmnioGraft$233
- PANORAMIC OPHTHALMOSCOPE$215
- iDose$132
- PURIFIED CORTROPHIN GEL$121
- Izervay$121
- RESTASIS$109
- OCT OPHTHALMOSCOPE$107
- NFC-700$107
- BEOVU$105
How this compares
$4,060 in reported general payments places this provider in the 90th percentile of 105 ophthalmology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 20 | $684 |
| Latanoprost | 75 | $653 |
| Ketorolac Tromethamine | 13 | $314 |
| Timolol Maleate | 16 | $192 |
| Diclofenac Sodium | 14 | $188 |
| Sertraline Hcl | 11 | $130 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Omaha
- Brandon BaartmanOmaha$226K
- Ronald KruegerOmaha$224K
- Lorraine ProvencherOmaha$220K
- Lance KuglerOmaha$41K
- Rao ChunduryOmaha$14K
- Shane HavensOmaha$6K
- Brandon MenkeOmaha$6K
- Sao LiuOmaha$5K
- Michael HalstedOmaha$4K
- Sao LiuOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.